Literature DB >> 7778172

Critical role of interleukin 4 in the induction of neonatal transplantation tolerance.

V Donckier1, M Wissing, C Bruyns, D Abramowicz, M Lybin, M L Vanderhaeghen, M Goldman.   

Abstract

Neonatal injection of semiallogeneic cells is known to promote differentiation of donor-specific CD4+ T cells into TH2-like cells in the peripheral lymphoid organs. We reasoned that the propensity of neonatal T cells to synthesize high levels of IL-4 might be involved in this polarization of the alloreactive response and thereby in the development of neonatal transplantation tolerance. First, analysis of cytokine gene expression in lymph nodes after neonatal injection of 10(7) (A/J x BALB/c)F1 cells in BALB/c mice indicated that IL-4 but not IL-2 is rapidly produced by CD4+ cells after allogeneic challenge in vivo. To determine whether the early production of IL-4 was involved in the establishment of allotolerance, BALB/c mice neonatally injected with (A/J x BALB/c)F1 spleen cells received on days 1 and 3 after birth 1 mg of anti-IL-4 mAb (11B11) or the same amount of control mAb. When grafted with A/J skin at 4 weeks, 88% of mice treated with control mAb retained their graft for more than 50 days, whereas rejection occurred within 30 days in 93% of mice treated with anti-IL-4 mAb. Analysis of T cell functions after in vitro restimulation with A/J spleen cells indicated that early IL-4 neutralization did not prevent donor-specific CTL unresponsiveness but allowed the emergence of alloreactive T cells secreting increased levels of IL-2 and IFN-gamma. We conclude that early production of IL-4 is critical for the establishment of neonatal transplantation tolerance in this strain combination, which has disparities across the entire H-2 region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778172

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Th1/Th2 balance in cancer, transplantation and pregnancy.

Authors:  M R Shurin; L Lu; P Kalinski; A M Stewart-Akers; M T Lotze
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Th2 alloimmunity counteracts Th17-type response in the neonatal establishment of lymphoid chimerism.

Authors:  Isabelle Debock; Véronique Flamand
Journal:  Chimerism       Date:  2011 Oct-Dec

4.  Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Authors:  Dennis Adeegbe; Robert B Levy; Thomas R Malek
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

5.  On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses.

Authors:  X C Li; M S Zand; Y Li; X X Zheng; T B Strom
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

6.  Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I-T-cell interactions.

Authors:  J D Coudert; G Foucras; C Demur; C Coureau; C Mazerolles; G Delsol; P Druet; J C Guéry
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 7.  Deciphering the role of eosinophils in solid organ transplantation.

Authors:  Oscar Okwudiri Onyema; Yizhan Guo; Atsushi Hata; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Am J Transplant       Date:  2019-11-18       Impact factor: 8.086

8.  The key regulators of adult T helper cell responses, STAT6 and T-bet, are established in early life in mice.

Authors:  Shawn Rose; Patricia Guevara; Sandra Farach; Becky Adkins
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

9.  B cells are dispensable for neonatal transplant tolerance induction.

Authors:  Wendy E Walker; Daniel R Goldstein
Journal:  Transplantation       Date:  2009-10-15       Impact factor: 4.939

10.  Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

Authors:  Shannon J Opiela; Robert B Levy; Becky Adkins
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.